Literature DB >> 22647974

Molecular imaging of thrombus: technology in evolution.

Jonathan R Lindner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22647974      PMCID： PMC3410533          DOI： 10.1161/CIRCULATIONAHA.112.112672

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  17 in total

1.  Novel single-chain antibody-targeted microbubbles for molecular ultrasound imaging of thrombosis: validation of a unique noninvasive method for rapid and sensitive detection of thrombi and monitoring of success or failure of thrombolysis in mice.

Authors:  Xiaowei Wang; Christoph E Hagemeyer; Jan David Hohmann; Ephraem Leitner; Paul C Armstrong; Fu Jia; Manfred Olschewski; Andrew Needles; Karlheinz Peter; Ingo Ahrens
Journal:  Circulation       Date:  2012-05-30       Impact factor: 29.690

2.  Conformation-specific blockade of the integrin GPIIb/IIIa: a novel antiplatelet strategy that selectively targets activated platelets.

Authors:  Meike Schwarz; Gerardene Meade; Patrick Stoll; Jari Ylanne; Nicole Bassler; Yung Chih Chen; Christoph E Hagemeyer; Ingo Ahrens; Niamh Moran; Dermot Kenny; Desmond Fitzgerald; Christoph Bode; Karlheinz Peter
Journal:  Circ Res       Date:  2006-06-15       Impact factor: 17.367

Review 3.  Contrast echocardiography.

Authors:  Beat A Kaufmann; Kevin Wei; Jonathan R Lindner
Journal:  Curr Probl Cardiol       Date:  2007-02       Impact factor: 5.200

4.  Detection of recent myocardial ischaemia by molecular imaging of P-selectin with targeted contrast echocardiography.

Authors:  Beat A Kaufmann; Christopher Lewis; Aris Xie; Ayoub Mirza-Mohd; Jonathan R Lindner
Journal:  Eur Heart J       Date:  2007-05-26       Impact factor: 29.983

5.  In vitro studies of a new thrombus-specific ultrasound contrast agent.

Authors:  E C Unger; T P McCreery; R H Sweitzer; D Shen; G Wu
Journal:  Am J Cardiol       Date:  1998-06-18       Impact factor: 2.778

6.  A novel site-targeted ultrasonic contrast agent with broad biomedical application.

Authors:  G M Lanza; K D Wallace; M J Scott; W P Cacheris; D R Abendschein; D H Christy; A M Sharkey; J G Miller; P J Gaffney; S A Wickline
Journal:  Circulation       Date:  1996-12-15       Impact factor: 29.690

7.  Molecular imaging of human thrombus with novel abciximab immunobubbles and ultrasound.

Authors:  Angelika Alonso; Alberto Della Martina; Mark Stroick; Marc Fatar; Martin Griebe; Sibylle Pochon; Michel Schneider; Michael Hennerici; Eric Allémann; Stephen Meairs
Journal:  Stroke       Date:  2007-03-22       Impact factor: 7.914

8.  Angioscopic follow-up study of coronary ruptured plaques in nonculprit lesions.

Authors:  Masamichi Takano; Shigenobu Inami; Fumiyuki Ishibashi; Kentaro Okamatsu; Koji Seimiya; Takayoshi Ohba; Shunta Sakai; Kyoichi Mizuno
Journal:  J Am Coll Cardiol       Date:  2005-03-01       Impact factor: 24.094

9.  Intravascular ultrasound molecular imaging of atheroma components in vivo.

Authors:  Andrew J Hamilton; Shao-Ling Huang; Drew Warnick; Mark Rabbat; Bonnie Kane; Ashwin Nagaraj; Melvin Klegerman; David D McPherson
Journal:  J Am Coll Cardiol       Date:  2004-02-04       Impact factor: 24.094

10.  Evidence for pre- to postsynaptic mismatch of the cardiac sympathetic nervous system in ischemic congestive heart failure.

Authors:  James H Caldwell; Jeanne M Link; Wayne C Levy; Jeanne E Poole; John R Stratton
Journal:  J Nucl Med       Date:  2008-01-16       Impact factor: 10.057
View more
  8 in total

1.  Multisite Thrombus Imaging and Fibrin Content Estimation With a Single Whole-Body PET Scan in Rats.

Authors:  Francesco Blasi; Bruno L Oliveira; Tyson A Rietz; Nicholas J Rotile; Pratap C Naha; David P Cormode; David Izquierdo-Garcia; Ciprian Catana; Peter Caravan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-08-13       Impact factor: 8.311

2.  Radiation Dosimetry of the Fibrin-Binding Probe ⁶⁴Cu-FBP8 and Its Feasibility for PET Imaging of Deep Vein Thrombosis and Pulmonary Embolism in Rats.

Authors:  Francesco Blasi; Bruno L Oliveira; Tyson A Rietz; Nicholas J Rotile; Helen Day; Pratap C Naha; David P Cormode; David Izquierdo-Garcia; Ciprian Catana; Peter Caravan
Journal:  J Nucl Med       Date:  2015-05-14       Impact factor: 10.057

Review 3.  Targeting of microbubbles: contrast agents for ultrasound molecular imaging.

Authors:  Shiying Wang; John A Hossack; Alexander L Klibanov
Journal:  J Drug Target       Date:  2018-01-09       Impact factor: 5.121

4.  Imaging High-Risk Atherothrombosis Using a Novel Fibrin-Binding Positron Emission Tomography Probe.

Authors:  Peter Caravan; Ilknur Ay; David Izquierdo-Garcia; Himashinie Diyabalanage; Ian A Ramsay; Nicholas J Rotile; Adam Mauskapf; Ji-Kyung Choi; Thomas Witzel; Valerie Humblet; Farouc A Jaffer; Anna-Liisa Brownell; Ahmed Tawakol; Ciprian Catana; Mark F Conrad
Journal:  Stroke       Date:  2021-12-30       Impact factor: 7.914

5.  In vivo molecular imaging of thrombosis and thrombolysis using a fibrin-binding positron emission tomographic probe.

Authors:  Ilknur Ay; Francesco Blasi; Tyson A Rietz; Nicholas J Rotile; Sreekanth Kura; Anna Liisa Brownell; Helen Day; Bruno L Oliveira; Richard J Looby; Peter Caravan
Journal:  Circ Cardiovasc Imaging       Date:  2014-04-28       Impact factor: 7.792

6.  Fibrin-targeted PET probes for the detection of thrombi.

Authors:  Katie L Ciesienski; Yan Yang; Ilknur Ay; Daniel B Chonde; Galen S Loving; Tyson A Rietz; Ciprian Catana; Peter Caravan
Journal:  Mol Pharm       Date:  2013-01-30       Impact factor: 4.939

Review 7.  Molecular imaging in cardiovascular disease: Which methods, which diseases?

Authors:  Jonathan R Lindner; Albert Sinusas
Journal:  J Nucl Cardiol       Date:  2013-12       Impact factor: 5.952

8.  Thrombus-Targeted Theranostic Microbubbles: A New Technology towards Concurrent Rapid Ultrasound Diagnosis and Bleeding-free Fibrinolytic Treatment of Thrombosis.

Authors:  Xiaowei Wang; Yannik Gkanatsas; Jathushan Palasubramaniam; Jan David Hohmann; Yung Chih Chen; Bock Lim; Christoph E Hagemeyer; Karlheinz Peter
Journal:  Theranostics       Date:  2016-03-20       Impact factor: 11.556
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.